22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives
BUFFALO, N.Y., March 03, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the world’s leading biotechnology company dedicated to improving health with reduced nicotine tobacco and advanced plant technologies in both hemp/cannabis and hops, today announced a new $21 million senior secured debenture financing to support increased working capital needs related to the significant growth outlook in both its VLN® and GVB business lines. The new three-year financing was issued at 5% original issuance discount (OID), will bear cash interest at a rate of 7% per annum, and commence principal amortization in the second year at a rate of 2% of the original balance per month. The Company has the option to redeem the facility early starting in the second year.
Related news for (XXII)
- From Web3 to Quantum: Small-Cap Innovators OFAL, SPRC, XXII Lead Market Movers as XHLD Builds Visibility
- Today’s Top Performers: MoBot’s Market Review 09/25/25 06:00 AM
- MoBot alert highlights: NASDAQ: OFAL, NASDAQ: PEPG, NASDAQ: XXII, NYSE: LAC, NYSE: ATCH (09/25/25 05:00 AM)
- Today’s Top Performers: MoBot’s Market Review 09/25/25 04:00 AM
- Breaking News: MoBot’s Latest Update as of 09/24/25 06:00 PM